Evidence map›Paper›PMID 19171735›Full record

Trial reportDiabetes care2009

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.

Tali Cukierman-Yaffe, Hertzel C Gerstein, Jeff D Williamson, Ronald M Lazar, Laura Lovato, Michael E Miller, Laura H Coker, Anne Murray, Mark D Sullivan, Santica M Marcovina and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 189 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
189citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

189 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. IL7RBrain and behavior · 2025
    Article
  20. Article

129 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Tali Cukierman-YaffeGertner Institute for Epidemiology and Health Policy Research, Endocrinology Institute Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. cukierm@mcmaster.ca
Hertzel C Gerstein
Jeff D Williamson
Ronald M Lazar
Laura Lovato
Michael E Miller
Laura H Coker
Anne Murray
Mark D Sullivan
Santica M Marcovina
Lenore J Launer
Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators

Funding

New York Stroke Trials Network of Columbia and Cornell (NYCCSTN)U10NS086728 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARSHALL, RANDOLPH S · 2013 to 2017
$2.0M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095183 · HC · MINNEAPOLIS MEDICAL RESEARCH FDN, INC. · PI GRIMM, RICHARD H · 1999 to 2000
$1.9M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095181 · HC · CASE WESTERN RESERVE UNIVERSITY · PI THIBONNIER, MARC · 1999 to 2000
$1.8M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095184 · HC · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BIGGER, J T · 1999 to 2000
$1.7M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095182 · HC · WAKE FOREST UNIVERSITY · PI GOFF, DAVID C · 1999 to 2000
$1.6M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUS-N01HC95178N01HC095178 · HC · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BYINGTON, ROBERT · 1999 to 2006
$1.5M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETER MELLLITN01HC095180 · HC · UNIVERSITY OF WASHINGTON · PI PROBSTFIELD, JEFFREY · 1999 to 2000
$1.5M
S-nitrosothiol analyzer for the clinical diagnosis of cardiovascular disease markR44HL095181 · NHLBI · ACCORD BIOMATERIALS, INC. · PI PISANO, MICHAEL R · 2010 to 2011
$1.4M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095179 · HC · MCMASTER UNIVERSITY · PI GERSTEIN, HERTZEL C · 1999 to 2000
$1.3M
S-nitrosothiol analyzer for the clinical diagnosis of cardiovascular disease markR43HL095181 · NHLBI · ACCORD BIOMATERIALS, INC. · PI HANDA, HILTESH · 2009 to 2009
$93k
Intramural NIH HHSNHLBI NIH HHS HC-99-16NHLBI NIH HHS N01 HC095178NHLBI NIH HHS N01 HC095179NHLBI NIH HHS N01 HC095180NHLBI NIH HHS N01 HC095181NHLBI NIH HHS N01 HC095182NHLBI NIH HHS N01 HC095183NHLBI NIH HHS N01 HC095184NHLBI NIH HHS N01-HC95178NHLBI NIH HHS N01-HC-95179NHLBI NIH HHS N01-HC-95180NHLBI NIH HHS N01-HC-95181NHLBI NIH HHS N01-HC-95182NHLBI NIH HHS N01-HC-95183NHLBI NIH HHS N01-HC-95184NHLBI NIH HHS Y01 HC001010NHLBI NIH HHS Y01 HC009035NHLBI NIH HHS Y1-HC-1010NHLBI NIH HHS Y1-HC-9035NINDS NIH HHS U10 NS086728
6 · The paper itself

Abstract

objectiveDiabetes is associated with cognitive decline and dementia. However, the relationship between the degree of hyperglycemia and cognitive status remains unclear. This was explored using baseline cognitive measures collected in the ongoing Memory in Diabetes (MIND) substudy of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. RESEARCH DESIGN AND

methodsThe relationship of A1C and fasting plasma glucose (FPG) levels to performance on four cognitive tests was assessed, adjusting for age and other determinants of cognitive status. The tests were the Digit Symbol Substitution Test (DSST), Mini Mental Status Examination (MMSE), Rey Auditory Verbal Learning Test, and Stroop Test.

resultsA statistically significant age-adjusted association was observed between the A1C level and the score on all four cognitive tests. Specifically, a 1% higher A1C value was associated with a significant 1.75-point lower DSST score (95% CI -1.22 to -2.28; P < 0.0001), a 0.20-point lower MMSE score (-0.11 to -0.28; P < 0.0001), a 0.11-point lower memory score (-0.02 to -0.19, P = 0.0142), and a worse score (i.e., 0.75 s more) on the Stroop Test (1.31-0.19, P = 0.0094). The association between the DSST score and A1C persisted in all multiple linear regression models. FPG was not associated with test performance.

conclusionsHigher A1C levels are associated with lower cognitive function in individuals with diabetes. The effect of glucose lowering on cognitive function will be determined by the ongoing ACCORD-MIND trial.

Indexed as

CognitionBlood GlucoseCardiovascular DiseasesDiabetes Mellitus, Type 2Diabetic AngiopathiesFemaleGlycated HemoglobinHumansMaleMemoryMental Status ScheduleMiddle AgedPsychological TestsRegression AnalysisReproducibility of ResultsBlood GlucoseGlycated Hemoglobin

Identifiers

PMID19171735
PMCPMC2628683

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.